510(k) Report

510(k) · Cleared

Cleared

BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes

K260128510(k) SpecialCleared Apr 15, 202689-day reviewClass II21 CFR 862.1675

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson and Company · JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

Cleared on Apr 15, 2026 as substantially equivalent to K022426 (Becton, Dickinson & CO, 2002) after an 89-day review. Its family tree reaches back 3 generations to 1988.

Decided
Apr 15, 2026
Review
89 days
Class
Class II
Product code
JKA
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K875117 (1988). 4 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK875117 Ciba Corning Balanced Heparin for CA++Ciba Corning Diagnostics Corp. · 1988
  2. 2 generations backK982922 Vacutainer Brand Blood Collection SyringeBecton Dickinson Vacutainer Systems · 1998
  3. 1 generation backK022426 BD Preset Blood Collection Syringe, BD a-Line Blood Collection…Becton, Dickinson & CO · 2002
  4. This deviceK260128 BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesBecton, Dickinson and Company · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K875117Ciba Corning Balanced Heparin for CA++Ciba Corning Diagnostics Corp.1988—
−2K982922Vacutainer Brand Blood Collection SyringeBecton Dickinson Vacutainer Systems1998—
−1K022426BD Preset Blood Collection Syringe, BD a-Line Blood Collection Syringe, Models…Becton, Dickinson & CO2002—
0 (this device)K260128BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesBecton, Dickinson and Company2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
FIG. 1 — Lineage of K260128, 1988–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JKA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JKA device

  1. #1 K200027 Blood Collection Needle with/without Holder…score 15.6 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K022426BD Preset Blood Collection Syringe, BD a-Line Blood Collection Syringe, Models 365313…
Summary page 5
…fication Regulation: 21 CFR § 862.1675 Review Panel: Clinical Chemistry Class: II Product Code: JKA Predicate Device: BD Preset™ and BD A-Line™ Blood Collection Syringe (K022426) 510(k) Reference: K022426 Classification Name: Blood Specimen Collection Device; 21 CFR §862.1675 1mL BD Preset™…
Becton, Dickinson & CO2002—

Also cleared against K022426: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 38 years and passes through 4 companies; a new generation was cleared every 10.6 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K022426.

How does its category compare?

All JKA devices

JKA Tubes, Vials, Systems, Serum Separators, Blood Collection: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · JKA

7in 2025

2007: 42008: 22009: 22010: 42012: 12013: 32014: 12015: 12016: 42017: 22018: 12019: 62020: 62021: 42022: 92023: 172024: 62025: 72026 (partial year): 8
2007high 17 (2023) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JKA

115in 2025

2007: 281 days median2010: 28 days median2013: 244 days median2016: 116 days median2019: 181 days median2020: 181 days median2021: 217 days median2022: 164 days median2023: 189 days median2024: 240 days median2025: 115 days median2026 (partial year): 250 days median
2007high 281 (2007) · low 28 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JKA

13in 2025

2007: 32008: 32009: 32010: 42011: 142012: 22013: 12014: 12015: 62016: 12017: 22018: 22019: 92021: 32022: 22023: 22025: 132026 (partial year): 1
2007high 14 (2011) · low 0 (2020)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JKA

6,089in 2025

2007: 732008: 782009: 422010: 372011: 672012: 542013: 332014: 682015: 412016: 652017: 2,0392018: 9,7312019: 6,4692020: 3,7742021: 3,6102022: 3,3752023: 4,4002024: 4,6092025: 6,089
2007high 9,731 (2018) · low 33 (2013)2025

MAUDE reports naming product code JKA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074281373
20082—378
20092—342
2010428437
20110—1467
20121—254
20133244133
20141—168
20151—641
20164116165
20172—22,039
20181—29,731
2019618196,469
2020618103,774
2021421733,610
2022916423,375
20231718924,400
2024624004,609
20257115136,089
202682501—

What is it indicated for?

The BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes are sterile, single-use, in vitro diagnostic medical devices specifically intended to be used for the collection and containment of whole blood specimens for the purpose of in vitro diagnostic testing which may include: pH, blood gases, electrolytes (including ionized calcium), metabolites, co-oximetry. The device is intended to be used by trained healthcare professionals.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K260128: BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K260128

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026